JNJ

233.01

+1.03%↑

ISRG

478.71

-3.54%↓

ABT

108.96

-0.46%↓

RDY

13.8

+1.55%↑

NEOG

10.27

+0.39%↑

JNJ

233.01

+1.03%↑

ISRG

478.71

-3.54%↓

ABT

108.96

-0.46%↓

RDY

13.8

+1.55%↑

NEOG

10.27

+0.39%↑

JNJ

233.01

+1.03%↑

ISRG

478.71

-3.54%↓

ABT

108.96

-0.46%↓

RDY

13.8

+1.55%↑

NEOG

10.27

+0.39%↑

JNJ

233.01

+1.03%↑

ISRG

478.71

-3.54%↓

ABT

108.96

-0.46%↓

RDY

13.8

+1.55%↑

NEOG

10.27

+0.39%↑

JNJ

233.01

+1.03%↑

ISRG

478.71

-3.54%↓

ABT

108.96

-0.46%↓

RDY

13.8

+1.55%↑

NEOG

10.27

+0.39%↑

Home・Aktien・Avita Therapeutics Inc

Avita Therapeutics Inc

Geschlossen

4.26 0.95

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

Max

4.31

Schlüsselkennzahlen
By Trading Economics
Einkommen	-3.3M -13M
Verkäufe	-1.4M 17M
Gewinnspanne	-77.289
Angestellte	260
EBITDA	-3.2M -11M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+2.04% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	12. Feb. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	8.2M 129M
Vorheriger Eröffnungskurs	3.31
Vorheriger Schlusskurs	4.26

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

8.83 / 9.77 Unterstützung & Widerstand

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Feb. 2026, 23:11 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3. Feb. 2026, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. Feb. 2026, 23:50 UTC

Market Talk

Nikkei May Decline After Hitting All-Time High -- Market Talk

3. Feb. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

3. Feb. 2026, 23:41 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3. Feb. 2026, 23:38 UTC

Ergebnisse

AMD Sales Climb on Help From Data-Center Business -- Update

3. Feb. 2026, 23:29 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3. Feb. 2026, 23:27 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3. Feb. 2026, 23:25 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3. Feb. 2026, 23:23 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3. Feb. 2026, 23:22 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3. Feb. 2026, 23:19 UTC

Market Talk

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3. Feb. 2026, 23:19 UTC

Market Talk

Global Equities Roundup: Market Talk

3. Feb. 2026, 22:56 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3. Feb. 2026, 22:40 UTC

Ergebnisse

Amdocs Extends Collaboration With T-Mobile

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q Adj EPS $1.81

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q Rev $1.16B

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q EPS $1.45 >

3. Feb. 2026, 22:38 UTC

Ergebnisse

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3. Feb. 2026, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3. Feb. 2026, 22:22 UTC

Akquisitionen, Fusionen, Übernahmen

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3. Feb. 2026, 22:14 UTC

Ergebnisse

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3. Feb. 2026, 22:13 UTC

Ergebnisse

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3. Feb. 2026, 22:12 UTC

Ergebnisse

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3. Feb. 2026, 22:10 UTC

Ergebnisse

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3. Feb. 2026, 22:10 UTC

Ergebnisse

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3. Feb. 2026, 22:10 UTC

Market Talk

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3. Feb. 2026, 22:10 UTC

Ergebnisse

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3. Feb. 2026, 22:09 UTC

Ergebnisse

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3. Feb. 2026, 22:09 UTC

Ergebnisse

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

2.04% Vorteil

12-Monats-Prognose

Durchschnitt 4.5 USD 2.04%

Hoch 5.5 USD

Tief 3.5 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

Buy

Halten

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Avita Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.